Trial
NCT02389231
Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Bordeaux
Collaborators
—
Condition
Autoimmune Hemolytic Anemia
Intervention
Interleukine-2
Why stopped
target number of inclusion not reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22